A retrospective study on iRoot BP Plus full pulpotomy for primary molars with partial irreversible pulpitis

Hua Xi Kou Qiang Yi Xue Za Zhi. 2024 Apr 1;42(2):242-248. doi: 10.7518/hxkq.2024.2023308.
[Article in English, Chinese]

Abstract

Objectives: This study aimed to observe the outcomes of iRoot BP Plus full pulpotomy in primary molars with partial irreversible pulpitis retrospectively.

Methods: Collect 102 cases of primary molars with partial irreversible pulpitis undergoing iRoot BP Plus full pulpotomy from January 2019 to August 2023, with a follow-up period of 24-47 months. Based on the presence of irreversible pulpitis symptoms before surgery, the included cases will be divided into asymptomatic group (n=53) and symptomatic group (n=49). Observe the clinical and imaging success rates of both groups.

Results: Clinical success rates were 96.2% and 97.9% in asymptomatic and symptomatic groups, and radiographic success rates were 96.2% and 93.9% respectively.

Conclusions: iRoot BP Plus full pulpotomy can be used for the treatment of primary molars with partial irreversible pulpitis under an enhanced pulpotomy protocol.

目的: 回顾性观察iRoot BP Plus冠髓切断术治疗乳磨牙部分不可复性牙髓炎的临床疗效。方法: 收集2019年1月—2023年8月行乳磨牙iRoot BP Plus冠髓切断术治疗且随访24~47个月的部分不可复性牙髓炎病例102例,根据术前有无不可复性牙髓炎症状将纳入病例分为无症状组(n=53)和有症状组(n=49),观察两组的临床和影像学成功率。结果: 无症状组和有症状组的临床成功率分别为96.2%和97.9%,影像学成功率分别为96.2%和93.9%。结论: 在高抗菌等级前提下,iRoot BP Plus冠髓切断术可以尝试用于治疗乳磨牙部分不可复性冠髓炎。.

Keywords: iRoot BP Plus; irreversible pulpitis; partial irreversible pulpitis; primary molar; pulpotomy.

MeSH terms

  • Calcium Compounds / therapeutic use
  • Humans
  • Molar / surgery
  • Pulpitis* / drug therapy
  • Pulpitis* / surgery
  • Pulpotomy* / methods
  • Retrospective Studies
  • Silicates / therapeutic use
  • Treatment Outcome

Substances

  • iRoot BP Plus
  • Silicates
  • Calcium Compounds

Grants and funding

[基金项目] 2023年度安徽省高校自然科学研究项目(2023AH050622)